- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 1.49M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 2.55M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 756.81K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$997.51K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.58M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $12.62M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $13.6M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $5.84M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $7.04M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.5M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$2.58M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $10.45M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $10.38M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.53M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $10.48M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $16.23M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $17.24M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.38M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.52M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.51 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.09 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.51 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.09 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $4.3M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.14M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$1.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.58M |
| Net Income | Q1 2025 · Jun 30, 2023 | −$1.58M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$1.3M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.5M |
| Revenue | Q1 2025 · Mar 31, 2025 | $3.08M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.74M |